Urology Doctors in Baton Rouge, LA Accepting Medicare

29 Urology doctors found. Showing 21 - 29

Thomas Edward Wills, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 2004, Baton Rouge, LA 70808 Phone: 225-769-2500    Fax: 225-769-9424

Stephen Randolph Vick, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 2004, Baton Rouge, LA 70808 Phone: 225-769-2500    Fax: 225-769-9424

Richard Gipson Carter, M.D. Urology Medicare: Medicare Enrolled Practice Location: 6323 Jefferson Hwy, Baton Rouge, LA 70806 Phone: 225-921-2422

Joseph Allen Fougerousse, MD Urology Medicare: Medicare Enrolled Practice Location: 8080 Bluebonnet Blvd Ste 3000, Baton Rouge, LA 70810 Phone: 225-766-8100    Fax: 225-408-6873

Andrew N Mccall, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 3000, Baton Rouge, LA 70810 Phone: 337-274-7566

Dr. Spyrie D. Mays, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3401 North Blvd, Suite 340, Baton Rouge, LA 70806 Phone: 225-381-2740    Fax: 225-381-2511

Dr. Andrew Zaruski, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044

Angelo Annaloro Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 2004, Baton Rouge, LA 70808 Phone: 225-769-2500    Fax: 225-769-9424

Ross Cockrell, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Baton Rouge, LA 70808 Phone: 225-769-4044    Fax: 225-246-9116

News Archive

Treatment method improves survival for advanced laryngeal cancer

Chemotherapy and radiation can be effective at treating cancer of the larynx, or voice box, without removing the organ that controls speech and swallowing. But it doesn't work for everyone.

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

LifeCycle Pharma A/S has announced positive top-line results from a Phase 2 clinical trial involving 58 patients comparing LCP-Tacro™ tablets administered once-daily versus Prograf® (tacrolimus) capsules (Astellas Pharma) administered twice-daily in de novo liver transplant patients for one year.

Allergan receives FDA approval for Natrelle 410 breast implant

The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.

BMG LABTECH doubles manufacturing area to meet global demand for microplate reader products

BMG LABTECH, a world leader in microplate readers, has recorded a rapid increase in revenue over the past years. A new company building provides the additional capacity required for the company's anticipated business growth over the longer term.

Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)